Gut Microbiome Linked to Alzheimer's Stages in New Study

A new multi-omics study published in Scientific Reports on 27 September 2026 has found that gut microbial composition, faecal metabolites, and peripheral immune proteins differ meaningfully across distinct stages of Alzheimer's disease (AD), suggesting the gut-brain connection may play a measurable role throughout the disease continuum — from early cognitive changes through to advanced dementia.

Why This Matters

Alzheimer's disease affects an estimated 900,000 people in the UK, with numbers projected to rise sharply in coming decades. Growing interest in gut health UK-wide has prompted researchers to look beyond the brain itself, examining how systemic immune and metabolic processes — many of them shaped by the gut microbiome — may contribute to neurodegeneration. UK microbiome research, supported by bodies such as the Wellcome Trust and MRC, has increasingly pointed to the gut-brain axis as a promising frontier for understanding dementia risk and progression.

Study Reveals Stage-Specific Gut and Immune Signatures

According to researchers led by Zhe Wei and colleagues, the cross-sectional analysis examined how gut microbial composition, faecal metabolites, and peripheral immune proteins varied not merely between healthy individuals and those with AD, but across specific stages of the Alzheimer's disease continuum. The study found that these three biological modules — gut microbiota, metabolites, and immune markers — showed stage-associated differences, implying that the gut-brain connection shifts in character as the disease progresses, rather than presenting a single, uniform biological signature.

What This Means for UK Readers and Researchers

For health-conscious adults in the UK, the findings add scientific weight to the idea that efforts to improve gut health naturally may have relevance beyond digestive wellbeing. The research supports a view, increasingly prominent in NHS and British Nutrition Foundation communications, that the microbiome is integral to whole-body health — including brain health. UK microbiome research institutions, including those at King's College London and the University of Oxford, are well positioned to build on these findings in future longitudinal studies.

This study underscores that Alzheimer's disease involves systemic biological changes detectable in the gut, not only the brain. As the gut-brain connection gains further evidential support, microbiome science may inform earlier intervention strategies — a priority for NHS dementia care pathways across the UK.

You might also like

• 7 Gut-Brain Secrets That Could Transform Your Mood
• How to Improve Gut Health Naturally in 5 Steps
• How to Improve Gut Health with Meditation

96 Bacterial Strains. Two Shots a Day.

GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?

Find out more →